Bi-Weekly Paclitaxel - Gemcitabine in Small Cell Lung Cancer Patients Pretreated with Platinum-Etoposide Chemotherapy

被引：0

作者：

Carrera Revilla, Sergio ^{[1
]}

Lopez Vivanco, Guillermo ^{[1
]}

Munoz Llarena, Alberto ^{[1
]}

Rubio Etxcbarria, Itziar ^{[1
]}

Sancho Gutierrez, Aintzane ^{[1
]}

Marrodan Ciordia, Ines ^{[1
]}

Manuel Mane, Juan ^{[1
]}

Ruiz De Lobera, Abigail ^{[1
]}

Ballesteros, David ^{[1
]}

Gutierrez, Eddy ^{[1
]}

机构：

[1] Cruces Hosp, Dept Med Oncol, Baracaldo, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S416 / S417

页数：2

共 50 条

[31] A PHASE II STUDY OF WEEKLY GEMCITABINE-TOPOTECAN IN PRETREATED SMALL CELL LUNG CANCER (SCLC) PATIENTS (PTS) [J].

Domine, M. ;

Gonzalez-Larriba, J. L. ;

Lopez-Vilarino, J. A. ;

Puente, J. ;

Rubio, G. ;

Alfonso, R. ;

Martin-Valades, J. I. ;

Rodriguez, L. ;

Izarzugaza, Y. ;

Lobo, F. .

ANNALS OF ONCOLOGY, 2010, 21 :160-160

[32] A PRELIMINARY-REPORT - CONCURRENT TWICE-DAILY RADIOTHERAPY PLUS PLATINUM-ETOPOSIDE CHEMOTHERAPY FOR LIMITED SMALL CELL LUNG-CANCER [J].

TURRISI, AT ;

GLOVER, DJ ;

MASON, BA .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (01) :183-187

[33] A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane plus platinum-based regimens [J].

Kosmas, Christos ;

Tsavaris, Nicolas ;

Syrigos, Konstantinos ;

Koutras, Angelos ;

Tsakonas, George ;

Makatsoris, Thomas ;

Mylonakis, Nicolas ;

Karabelis, Athanasios ;

Stathopoulos, George P. ;

Kalofonos, Haralambos P. .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (01) :51-59

[34] Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer [J].

Yilmaz, Feride ;

Yasar, Serkan ;

Tatar, Omer Denizhan ;

Yildirim, Hasan Cagri ;

Guven, Deniz Can ;

Akyildiz, Arif ;

Chalabiyev, Elvin ;

Aktas, Burak Yasin ;

Arik, Zafer ;

Erman, Mustafa .

BMC CANCER, 2024, 24 (01)

[35] First-line durvalumab plus platinum-etoposide in Japanese patients with extensive-stage small-cell lung cancer [J].

Mochizuki, Eisuke ;

Matsuura, Shun ;

Koshimizu, Naoki ;

Kojima, Suguru ;

Sakurai, Shogo ;

Kishimoto, Satoshi ;

Niwa, Mitsuru ;

Watanuki, Masayuki ;

Inaba, Ryunosuke ;

Takuma, Sho ;

Inoue, Yusuke ;

Karayama, Masato ;

Inui, Naoki ;

Suda, Takafumi .

CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2025, 44

[36] Association of nephrotoxicity during platinum-etoposide doublet therapy with UGT1A1 polymorphisms in small cell lung cancer patients [J].

Anai, Satoshi ;

Iwama, Eiji ;

Yoneshima, Yasuto ;

Otsubo, Kohei ;

Tanaka, Kentaro ;

Nakanishi, Yoichi ;

Okamoto, Isamu .

LUNG CANCER, 2018, 126 :156-161

[37] A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients [J].

Correale, P. ;

Cerretani, D. ;

Remondo, C. ;

Martellucci, I. ;

Marsili, S. ;

La Placa, M. ;

Sciandivasci, A. ;

Paolelli, L. ;

Pascucci, A. ;

Rossi, M. ;

Di Bisceglie, M. ;

Giorg, G. ;

Gotti, G. ;

Francini, G. .

ONCOLOGY REPORTS, 2006, 16 (01) :133-140

[38] Phase I trial of bi-weekly docetaxel combined with carboplatin for patients with non-small cell lung cancer. [J].

Inoue, A ;

Ishida, T ;

Saijo, Y ;

Maemondo, M ;

Suzuki, T ;

Kimura, Y ;

Ohkouchi, S ;

Nukiwa, T .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :676S-676S

[39] Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer [J].

Patricia M. M. B. Soetekouw ;

Johanna N. H. Timmer-Bonte ;

Miep A. van der Drift ;

Frank van Leeuwen ;

Michiel Wagenaar ;

Lya van Die ;

Jan Bussink ;

Vivianne C. G. Tjan-Heijnen .

International Journal of Clinical Oncology, 2013, 18 :988-996

[40] A phase II study of weekly paclitaxel and gemcitabine as second line chemotherapy in non small cell lung cancer (NSCLC): Preliminary report [J].

Dongiovanni, V ;

Buffoni, L ;

Dongiovanni, D ;

Occelli, M ;

Navello, C ;

Berletto, O .

ANNALS OF ONCOLOGY, 2000, 11 :4-4

← 1 2 3 4 5 →